HDT Bio Competitors and Similar CompaniesClear all
HDT Bio's competitors and similar companies include Tvardi Therapeutics, Biocon, Takeda Oncology and Kyowa Kirin.
 HDT Bio HDT Bio is a biopharmaceutical company intended to develop biotherapeutics for oncology and infectious disease applications. |  Tvardi Therapeutics Tvardi Therapeutics is a biotechnology company developing medicines for the treatment of cancer, chronic inflammation, and fibrosis. |  Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 1978 | Founding Date 1993 | Founding Date 2008 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations Houston, US HQ Houston, US | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Cambridge, US HQ | |
Employees | Employees 63 | Employees 19 | Employees 16,5612% increase | Employees 1,6441% decrease | Employees 5,669 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods N/A | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit N/A | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income N/A | Net income ¥67b (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 3m (over 5 years ago) | Latest funding round $ 74m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 11.3m | Total funding raised $ 88m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tvardi Therapeutics
HQ
Houston, US
Employees
19
Tvardi Therapeutics is a biotechnology company developing medicines for the treatment of cancer, chronic inflammation, and fibrosis.
View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyTakeda Oncology
HQ
Cambridge, US
Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company